+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergy Immunotherapy Market Research Report by Allergy Type, by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4905050
  • Report
  • July 2021
  • Region: Global
  • 199 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Allergy Immunotherapy Market will Grow to USD 5,730.44 Million by 2026, at a CAGR of 8.40%

FEATURED COMPANIES

  • Aimmune Therapeutics, Inc
  • Allergy Therapeutics
  • ASIT Biotech SA
  • DBV Technologies SA
  • HollisterStier Allergy
  • Merck KGaA
The Global Allergy Immunotherapy Market size was estimated at USD 3,530.29 Million in 2020 and expected to reach USD 3,815.19 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.40% to reach USD 5,730.44 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Allergy Immunotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Allergy Type, the Allergy Immunotherapy Market was examined across Allergic Rhinitis, Asthma, Food Allergy, and Venom Allergy.
  • Based on Distribution Channel, the Allergy Immunotherapy Market was examined across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy and Drug Stores.
  • Based on Type, the Allergy Immunotherapy Market was examined across SCIT and SLIT.
  • Based on Geography, the Allergy Immunotherapy Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Immunotherapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Immunotherapy Market, including Adamis Pharmaceuticals Corporation, Aimmune Therapeutics, Inc, ALK, ALK-Abelló A/S, Allergy Therapeutics, Allovate, LLC, Anergis SA, ASIT Biotech SA, Biomay AG, Circassia, DBV Technologies SA, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, Inimmune Corporation, Jubilant Life Sciences Ltd, LETIPharma GmBH, Merck KGaA, Mylan N.V., Sandoz, Stallergenes Greer PLC, and Torii Pharmaceutical Co. Ltd.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Allergy Immunotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Immunotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Immunotherapy Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Immunotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Immunotherapy Market?
6. What is the market share of the leading vendors in the Global Allergy Immunotherapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Allergy Immunotherapy Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aimmune Therapeutics, Inc
  • Allergy Therapeutics
  • ASIT Biotech SA
  • DBV Technologies SA
  • HollisterStier Allergy
  • Merck KGaA
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Allergy Type Outlook
3.4. Distribution Channel Outlook
3.5. Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in demand due to increasing prevalence of allergies
5.1.1.2. Surge in demand due to shift in lifestyle and environmental factors
5.1.2. Restraints
5.1.2.1. Higher upfront cost of treatment
5.1.2.2. Risk of side effects such redness, swelling, and tenderness
5.1.3. Opportunities
5.1.3.1. Increasing healthcare expenditure in the developing economies
5.1.3.2. Rising awareness among people about advanced immunotherapies
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Allergy Immunotherapy Market, by Allergy Type
6.1. Introduction
6.2. Allergic Rhinitis
6.3. Asthma
6.4. Food Allergy
6.5. Venom Allergy

7. Allergy Immunotherapy Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacy
7.3. Online Pharmacy
7.4. Retail Pharmacy and Drug Stores

8. Allergy Immunotherapy Market, by Type
8.1. Introduction
8.2. SCIT
8.3. SLIT

9. Americas Allergy Immunotherapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Allergy Immunotherapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Allergy Immunotherapy Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Adamis Pharmaceuticals Corporation
13.2. Aimmune Therapeutics, Inc
13.3. ALK
13.4. ALK-Abelló A/S
13.5. Allergy Therapeutics
13.6. Allovate, LLC
13.7. Anergis SA
13.8. ASIT Biotech SA
13.9. Biomay AG
13.10. Circassia
13.11. DBV Technologies SA
13.12. DESENTUM OY
13.13. HAL Allergy B.V.
13.14. HollisterStier Allergy
13.15. Inimmune Corporation
13.16. Jubilant Life Sciences Ltd
13.17. LETIPharma GmBH
13.18. Merck KGaA
13.19. Mylan N.V.
13.20. Sandoz
13.21. Stallergenes Greer PLC
13.22. Torii Pharmaceutical Co. Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2026
FIGURE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 23. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 30. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2026
FIGURE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 36. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 37. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 39. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 40. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 41. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 42. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 45. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 47. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 53. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 54. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 60. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 18. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 19. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 20. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 21. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 22. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 23. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 24. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 25. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 26. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 27. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 28. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 29. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 30. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 31. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 35. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 36. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 37. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 39. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 40. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 41. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 42. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 43. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 44. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 45. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 46. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 47. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 48. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 49. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 50. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 51. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 52. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 53. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 54. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 55. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 56. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 57. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 58. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 59. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 60. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 61. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 62. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 63. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 64. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 65. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 66. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 67. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 68. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 69. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 74. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 75. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 76. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 77. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 78. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 79. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 80. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 81. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 82. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 83. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 84. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 85. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 86. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 87. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 88. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 89. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 90. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 91. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 92. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 93. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 94. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 95. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 96. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 97. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 98. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 99. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 100. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 104. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2026 (USD MILLION)
TABLE 105. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 106. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 107. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: SCORES
TABLE 108. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: RANKING
TABLE 111. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 112. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MERGER & ACQUISITION
TABLE 113. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 114. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 115. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: INVESTMENT & FUNDING
TABLE 116. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 117. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Adamis Pharmaceuticals Corporation
  • Aimmune Therapeutics, Inc
  • ALK
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Allovate, LLC
  • Anergis SA
  • ASIT Biotech SA
  • Biomay AG
  • Circassia
  • DBV Technologies SA
  • DESENTUM OY
  • HAL Allergy B.V.
  • HollisterStier Allergy
  • Inimmune Corporation
  • Jubilant Life Sciences Ltd
  • LETIPharma GmBH
  • Merck KGaA
  • Mylan N.V.
  • Sandoz
  • Stallergenes Greer PLC
  • Torii Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll